金科股份(000656.SZ):金科服務今日正式登陸港交所
格隆匯11月17日丨金科股份(000656.SZ)公佈,經中國證監會《關於核准金科智慧服務集團股份有限公司發行境外上市外資股的批覆》(證監許可[2020]2564號)核准,公司控股子公司金科服務向香港聯交所遞交公開發行境外上市外資股(H股)並在香港聯交所主板上市的申請,且已獲香港聯交所批准。
該次金科服務共發行約1.33億股H股(假設超額配售權未獲行使),發行完成後總股本增加至約6.33億股,公司共持有金科服務約3.42億股,佔其發行完成後總股本的53.97%。
金科服務的股票於2020年11月17日在香港聯交所主板上市交易,股票代碼為“09666.HK”,股票中文簡稱為“金科服務”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.